ARTICLE | Clinical News
Enbrel etanercept regulatory update
October 4, 2004 7:00 AM UTC
WYE received EU approval for Enbrel etanercept, a TNF alpha inhibitor, to treat moderate to severe plaque psoriasis in adults who failed to respond to, have a contraindication to or are intolerant of...